Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
CENTER OF MOLECULAR IMMUNOLOGY
Trials shown by sponsor
Public title
Date of Registration
State
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer
08/07/2015
Registered
Racotumomab-alum cancer vaccine for solid tumors in pediatric patients
15/12/2015
Registered
CIMAbior® in CD20-positive B-cell Non-Hodgkin Lymphoma
05/09/2017
Registered
NAcGM3/VSSP-aids-patients drug resistant to antiretroviral treatment-Phase I-II
22/04/2016
Registered
Nimotuzumab inoperable esophageal epithelial tumors, Phase IV
30/06/2016
Registered
NeuroEPO in patients with Mild-Moderate Alzheimer's disease
01/02/2017
Registered
NeuroEPO in patients with Parkinson disease stage II-III
01/02/2017
Registered
Combined NGcGM3/VSSP and Nimotuzumab in advanced non-small cell lung cancer (NSCLC)
30/04/2018
Registered
NGcGM3/VSSP in patients with metastatic hormone-receptor positive and HER2 negative breast cancer
28/11/2016
Registered
Nimotuzumab-pancreatic cancer-adults-Phase IV.
30/04/2017
Registered
Nimotuzumab cold kit for the immunodiagnosis of solid tumors
05/10/2018
Registered
CIMAvax-EGF-Platelets-Adults- Lung Cancer
03/08/2018
Registered
CIMAvax-EGF® in metastatic asymptomatic or mildly symptomatic Castration Resistant Prostate Cancer patients. Phase II-III Clinical Trial
17/10/2018
Registered
VSSP in metastasic renal cell carcinoma
08/08/2018
Registered
Racotumomab vaccine- Lung Cancer- Adults-predictors of response - Exploratory
09/07/2018
Registered
NeuroEPO in stroke
02/08/2018
Registered
Itolizumab Safety and Efficacy Study in Covid 19
26/03/2021
Registered
VSSP in renal cell carcinoma
08/04/2021
Registered
Itolizumab-Plasmapheresis in patients with COVID-19
30/06/2021
Registered
VSSPs in renal carcinoma.
21/06/2023
Registered
« first
‹ previous
1
2
3
4
5
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform